// App-Quantinova.ai

OT1-02-02 : The DETECT study program Personalized treatment in metastatic breast cancer based on circulating tumor cells

Researchers

Presenter

  • Schramm A

Principal Investigators

  • Huober J

  • Aktas B

  • Pantel K

  • Meier-Stiegen F

  • Wimberger P

  • Kummel S

  • Gebauer G

  • Muller L

  • Janni W

  • Fehm T

  • Jager B

  • Rack B

  • Trapp E

  • Fasching PA

  • Taran F-A

  • Hartkopf A

  • Schneeweiss A

  • Muller V

Medical Centers

  • Department of Gynecology and Obstetrics, University Hospital Dresden, Dresden, Germany

  • Private Practice Onkologie UnterEms, Leer Ostfriesland Leer, Leer, Germany

  • Gynecology and Obstetrics, Klinikum der Ludwig-Maximilians-Universitat, Munich, Germany

  • University Hospital Eppendorf Frauenklinik, Hamburg, Germany

  • Gynecology and Obstetrics, University Hospital Hamburg-Eppendorf, Hamburg, Germany

  • Gynecology and Obstetrics, University Hospital Tubingen, Tuebingen, Germany

  • University Clinic Heidelberg, Heidelberg, Germany

  • University of Ulm, Ulm, Germany

  • Department of Gynecology and Obstetrics Heinrich-Heine-University Dusseldorf, Duesseldorf, Germany

  • Gynecology and Obstetrics, University Hospital Dresden, Technische Universitat Dresden, Dresden, Germany

  • Interdisciplinary Breast Center Unit Kliniken-Essen-Mitte, Essen, Germany

  • Gynecology and Obstetrics, University Hospital Tubingen, Tuebingen, Germany

  • Gynecology Marienhospital Hamburg, Hamburg, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • Doxorubicin Hydrochloride

  • Capecitabine

  • Anastrozole

  • Trastuzumab

  • Vinorelbine

  • Doxorubicin

  • Everolimus

  • Exemestane

  • Paclitaxel

  • Pertuzumab

  • Docetaxel

  • Letrozole

  • Tamoxifen

  • Lapatinib

  • Eribulin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved